cDNA microarray analysis in multiple sclerosis lesions: Detection of genes associated with disease activity

Brain

Volumn 126, Issue 5, 2003, Pages 1048-1057

  Mycko, Marcin P ^a   Papoian, Ruben ^b   Boschert, Ursula ^b   Raine, Cedric S ^c   Selmaj, Krzysztof W ^a,c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Brain tissue; Chronic active lesions; Chronic silent lesions; Differential gene expression; Multiple sclerosis

Indexed keywords

COMPLEMENTARY DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DNA MICROARRAY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

BRAIN; CELL CYCLE PROTEINS; CHRONIC DISEASE; CYTOKINES; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LOSS OF HETEROZYGOSITY; MULTIPLE SCLEROSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CELL SURFACE; SECOND MESSENGER SYSTEMS; TRANSCRIPTION FACTORS;

EID: 0242432319     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg107     Document Type: Article

References (42)

1. Armstrong RC, Kim JG, Hudson LD. Expression of myelin transcription factor I (MyTI), a 'zinc-finger' DNA-binding protein, in developing oligodendrocytes. Glia 1995; 14: 303-21.
2. Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, Oliveira-dos-Santos A, et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cb1-b. Nature 2000; 403: 211-6.
3. Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001; 14: 303-13.
4. Blakemore WF, Keirstead HS. The origin of remyelinating cells in the central nervous system. J Neuroimmunol 1999; 98: 69-76.
5. Brosnan CF, Battistini L, Gao Y-L, Raine CS, Aquino DA. Heat shock proteins and multiple sclerosis. J Neuropathol Exp Neurol 1996; 55: 389-402.
6. Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995; 37: 424-35.
7. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996; 383: 716-9.
8. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001; 294:1731-5.
9. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000; 20: 6404-12.
10. Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M, et al. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 1998; 121: 1869-87.
11. Chen J, Fujii K, Zhang L, Roberts T, Fu H. Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase I through a MEK-ERK independent mechanism. Proc Natl Acad Sci USA 2001; 98: 7783-8.
12. Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, Hu RJ, et al. Cb1-b regulates the CD28 dependence of T-cell activation. Nature 2000; 403: 216-20.
13. DeGroot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F, et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001; 124: 1635-45.
14. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, et al. A full genome search in multiple sclerosis. Nature Genet 1996; 13: 472-6.
15. Gay FW, Drye TJ, Dick GW, Esiri MM. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 1997; 120: 1461-83.
16. Gobin SJ, Montagne L, Van Zutphen M, Van Der Valk P, Van Den Elsen PJ, De Groot CJ. Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions. Glia 2001; 36: 68-77.
17. Guo AC, Jewells VL, Provenzale JM. Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging. AJNR Am J Neuroradiol 2001; 22: 1893-900.
18. Hasko G, Kuhel DG, Chen JF, Schwarzschild MA, Deitch EA, Mabley JG, et al. Adenosine inhibits IL-12 and TNF-[α] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 2000; 14: 2065-74.
19. Ibrahim SM, Mix E, Bottcher T, Koczan D, Gold R, Rolfs A, et al. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain 2001; 124: 1927-38.
20. Karp CL, van Boxel-Dezaire AH, Byrnes AA, Nagelkerken L. Interferon-β in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10? Curr Opin Neurol 2001; 14: 361-8.
21. Kim JG, Hudson LD. Novel member of the zinc finger superfamily: C2-HC finger that recognizes a glia-specific gene. Mol Cell Biol 1992; 12: 5632-9.
22. Krawczyk C, Bachmaier K, Sasaki T, Jones GR, Snapper BS, Bouchard D, et al. Cb1-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 2000; 13: 463-73.
23. Lapteva N, Ando Y, Nieda M, Hohjoh H, Okai M, Kikuchi A, et al. Profiling of genes expressed in human monocytes and monocyte-derived dendritic cells using cDNA expression array. Br J Haematol 2001; 114: 191-7.
24. Lassmann H, Raine CS, Antel J, Prineas JW. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 1998; 86: 213-7.
25. Lee IH, Li WP, Hisert KB, Ivashkiv LB. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion. J Exp Med 1999; 190: 1263-74.
26. Liu JS, Zhao ML, Brosnan CF, Lee SC. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 2001; 158: 2057-66.
27. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002; 8: 500-8.
28. McKenna HJ. Role of hematopoietic growth factors/flt3 ligand in expansion and regulation of dendritic cells. Curr Opin Hematol 2001; 8: 149-54.
29. Multiple Sclerosis Genetics Group. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genet 1996; 13: 469-71.
30. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
31. Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, Maraskovsky E, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999; 96: 1036-41.
32. Raine CS. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 1994; 36 Suppl: S61-72.
33. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet 1996; 13: 464-8.
34. Siger-Zajdel M, Selmaj K. Magnetization transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 71: 752-6.
35. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol 2000; 26: 133-42.
36. Soane L, Cho HJ, Niculescu F, Rus H, Shin ML. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J Immunol 2001; 167: 2305-11.
37. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996; 85: 299-302.
38. Steinman L. Gene microarrays and experimental demyelinating disease: a tool to enhance serendipity. Brain 2001; 124: 1897-9.
39. Valdo P, Stegagno C, Mazzucco S, Zuliani E, Zanusso G, Moretto G, et al. Enhanced expression of NGF receptors in multiple sclerosis lesions. J Neuropathol Exp Neurol 2002; 61: 91-8.
40. Wensky A, Marcondes MC, Lafaille JJ. The role of IFN-γ in the production of Th2 subpopulations: implications for variable Th2-mediated pathologies in autoimmunity. J Immunol 2001; 167: 3074-81.
41. Whitney LW, Becker KG, Tresser NJ, Caballero-Ramos Cl, Munson PJ, Prabhu VV, et al. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays. Ann Neurol 1999; 46: 425-8.
42. Woodroofe MN, Bellamy AS, Feldmann M, Davison AN, Cuzner ML. Immunocytochemical characterization of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci 1986; 74: 135-52.